BILIARY LIPID-COMPOSITION DURING TREATMENT WITH DIFFERENT HYPOLIPEMIC DRUGS

被引:92
作者
ANGELIN, B
EINARSSON, K
LEIJD, B
机构
[1] Department of Medicine, Karolinska Institutet, Serafimerlasarettet, Stockholm
关键词
Bile acid; cholesterol; cholestyramine; clofibrate; gallstone disease; hyperlipoproteinaemia; nicotinic acid;
D O I
10.1111/j.1365-2362.1979.tb00921.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abstract. In an attempt to clarify the possible lithogenic effects of commonly used hypolipidaemic drugs, gallbladder bile was obtained from patients with primary hyperlipoproteinaemia before and during treatment with nicotinic acid (n= 13), cholestyramine (n= 19), clofibrate (n= 11), and a combination of cholestyramine and clofibrate (n= 11). Each treatment period was minimum 6 weeks, and standardized dietary conditions were obtained. Both nicotinic acid and clofibrate treatment caused an increase in biliary cholesterol concentration relative to biliary total lipids (bile acids, phospholipids, and cholesterol). During cholestyramine medication the relative cholesterol concentration fell. A combination of cholestyramine with clofibrate medication led to a decrease of bile saturation to pretreatment levels in nine of the eleven subjects. In the other two a further increase in the cholesterol saturation of the bile occurred. Treatment with nicotinic acid and clofibrate but not with cholestyramine is thus probably associated with an increased risk for development of cholesterol gallstones. It is suggested that addition of cholestyramine may be a possible way to prevent the lithogenic effect of clofibrate in patients with hyperlipoproteinaemia when not only hypocholesterolaemic but also hypotriglyceridaemic effects are wanted. Copyright © 1979, Wiley Blackwell. All rights reserved
引用
收藏
页码:185 / 190
页数:6
相关论文
共 36 条
[1]   PHYSICOCHEMICAL BASIS OF CHOLESTEROL GALLSTONE FORMATION IN MAN [J].
ADMIRAND, WH ;
SMALL, DM .
JOURNAL OF CLINICAL INVESTIGATION, 1968, 47 (05) :1043-&
[2]  
AHLBERG J, AM J DIG DIS
[3]   EFFECT OF CHENODEOXYCHOLIC ACID ON SERUM AND BILIARY LIPIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIA [J].
ANGELIN, B ;
EINARSSON, K ;
LEIJD, B .
CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 54 (04) :451-455
[4]  
ANGELIN B, 1978, J LIPID RES, V19, P1004
[5]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[6]   REVERSAL OF CLOFIBRATE-INDUCED CHOLESTEROL OVERSATURATION OF BILE WITH CHENODEOXYCHOLIC ACID [J].
BATESON, MC ;
ROSS, PE ;
MURISON, J ;
BOUCHIER, IAD .
BRITISH MEDICAL JOURNAL, 1978, 1 (6121) :1171-1173
[7]  
BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891
[8]  
Carlson K, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P32
[9]  
COOPER J, 1975, LANCET, V1, P1083
[10]   EFFECT OF CHOLESTYRAMINE ON ELIMINATION OF CHOLESTEROL AS BILE-ACIDS IN PATIENTS WITH HYPERLIPOPROTEINEMIA TYPE-II AND IV [J].
EINARSSON, K ;
HELLSTROM, K ;
KALLNER, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1974, 4 (06) :405-410